Skip to content

Optimizing clinical management of neonatal hypoglycemia – a quality improvement project

Optimizing clinical management of neonatal hypoglycemia – a quality improvement project

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028165
Enrollment
1000
Registered
2022-04-22
Start date
2022-05-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

P70

Interventions

Group 1: Patients with neonatal hypoglycemia before / after implementation of the new AWMF guideline at the UMG Group 2: Patients with neonatal hypoglycemia born at one of the three hospitals (UMG/ NB

Sponsors

Universitätsmedizin Göttingen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Days

Inclusion criteria

Inclusion criteria: - children of diabetic mothers (gestational diabetes or pre-existing diabetes) - hypothrophic ( 90. percentile) neonates - premature babies (36 - 36;6 weeks of pregnancy, excluding those, who were hospitalized anyway) - extended pregnancy (= 42+0 weeks of pregnancy) - maternal medication with beta blockers - perinatal acidosis (pH 140 / 90 mmHg)

Exclusion criteria

Exclusion criteria: - premature babies (< 36 weeks of pregnancy) - neonates who were hospitalized at the neonatal department for another reason

Design outcomes

Primary

MeasureTime frame
Validation of the successful implementation of the AWMF-guideline and a resulting improvement of the hypoglycemia management.

Secondary

MeasureTime frame
Effectiveness comparison of the different neonatal hypoglycemia treatment strategies at the three birth clinics named above.

Countries

Germany

Contacts

Public ContactJana-Katharina Dieks

Universitätsmedizin Göttingen

jana.dieks@med.uni-goettingen.de+49 551 3922550

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026